1 active not recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow ALN-4324: new trials by email Literature Review of ALN-4324 trials Research Report on ALN-4324
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus ALN-4324, Placebo - Type 2 Diabetes Mellitus (T2DM) | Phase 2 | Recruiting | Alnylam Pharmaceuticals | 24 | 2026-01-15 | 2026-10-20 |
| A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM ALN-4324, Placebo - Obese or Overweight Healthy Volunteers, Type 2 Diabetes Mellitus (T2DM) | Phase 1 / Phase 2 | Active not recruiting | Alnylam Pharmaceuticals | 105 | 2025-03-03 | 2026-10-20 |
Diabetes Mellitus, Type 2 (2) · Obesity (1)
United States (2) · Argentina (1) · Canada (1) · Chile (1) · Germany (1) · Poland (1)